Recognising the people impacted by hepatitis this Hepatitis Awareness Week – Cancer Institute NSW
Cancer Institute NSW shared a post on LinkedIn:
“This Hepatitis Awareness Week we are recognising the people impacted by hepatitis, and how we can create a better future.
We are proud to be supporting research that is working to change the face of hepatitis and liver cancer in NSW and beyond.
Learn about Professor Jacob George and Dr. Rekha Jayaram Rao, and how they are making a difference.”
Tracey O’Brien shared this post, adding:
“Chronic hepatitis B and C infections are leading causes of liver cancer – one of the fastest growing cancer types in Australia – but thanks to vaccines and effective treatments, this upward trend can be reversed.
While a significant portion of liver cancers can be prevented, there are still many people across NSW who don’t realise they’re living with hepatitis until it’s too late.
This Hepatitis Awareness Week, the Cancer Institute NSW is highlighting the importance of hepatitis B vaccination and for people at higher risk of hepatitis to speak with their healthcare provider about testing.
Professor Jacob George, renowned liver specialist and Dr. Rekha Jayaram Rao, a General Practitioner who works closely with communities at higher risk of hepatitis, share their expert advice and insights on how at risk communities can reduce their risk of liver cancer.”
Sources: Cancer Institute NSW/LinkedIn and Tracey O’Brien/LinkedIn
Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was the Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant and Cellular Therapy Program.
Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; Vice Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and Vice President of the Australian and New Zealand Children’s Oncology Group.